MOZ directs the distal-less homeobox gene expression program during craniofacial development
- Vanyai, HK; Garnham, A; May, RE; McRae, HM; Collin, C; Wilcox, S; Smyth, GK; Thomas, T; Voss, AK;
Publication Year 2019-07-24, Volume 146, Issue #14, Page pii: dev175042
- Journal Title
- Publication Type
- Journal Article
- Oral clefts are common birth defects. Individuals with oral clefts who have identical genetic mutations regularly present with variable penetrance and severity. Epigenetic or chromatin-mediated mechanisms are commonly invoked to explain variable penetrance. However, specific examples of these are rare. Two functional copies of the MOZ (KAT6A, MYST3) gene, encoding a MYST family lysine acetyltransferase chromatin regulator, are essential for human craniofacial development, but the molecular role of MOZ in this context is unclear. Using genetic interaction and genomic studies, we have investigated the effects of loss of MOZ on the gene expression program during mouse development. Among the more than 500 genes differentially expressed after loss of MOZ, 19 genes had previously been associated with cleft palates. These included four distal-less homeobox (DLX) transcription factor-encoding genes, Dlx1, Dlx2, Dlx3 and Dlx5 and DLX target genes (including Barx1, Gbx2, Osr2 and Sim2). MOZ occupied the Dlx5 locus and was required for normal levels of histone H3 lysine 9 acetylation. MOZ affected Dlx gene expression cell-autonomously within neural crest cells. Our study identifies a specific program by which the chromatin modifier MOZ regulates craniofacial development.
- WEHI Research Division(s)
- Bioinformatics; Epigenetics And Development; Advanced Technology And Biology
- PubMed ID
- Publisher's Version
- NHMRC Grants
- NHMRC/1010851, NHMRC/1008699, NHMRC/1051078, NHMRC/1003435, NHMRC/575512, NHMRC/1081421, NHMRC/1058892,
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2019-08-13 12:35:10Last Modified: 2019-08-13 01:00:04